These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9833269)
1. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland]. Zurn P; Danthine JP Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269 [TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509 [TBL] [Abstract][Full Text] [Related]
3. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness. Harris A; Yong K; Kermode M Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989 [TBL] [Abstract][Full Text] [Related]
4. [Introduction of general hepatitis B vaccination in Switzerland]. Zimmermann H; Vaudaux B; Kammerlander R Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270 [TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness. Vimolket T; Poovorawan Y Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440 [TBL] [Abstract][Full Text] [Related]
6. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Krahn M; Detsky AS Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635 [TBL] [Abstract][Full Text] [Related]
7. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Bloom BS; Hillman AL; Fendrick AM; Schwartz JS Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448 [TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents. Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794 [TBL] [Abstract][Full Text] [Related]
9. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents]. Szucs TD; Smala A; Berger K; Windorfer A Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation. Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389 [TBL] [Abstract][Full Text] [Related]
11. Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis. Fendrick AM; Lee JH; LaBarge C; Glick HA Arch Pediatr Adolesc Med; 1999 Feb; 153(2):126-36. PubMed ID: 9988242 [TBL] [Abstract][Full Text] [Related]
12. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Hung HF; Chen TH Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755 [TBL] [Abstract][Full Text] [Related]
13. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study. Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947 [TBL] [Abstract][Full Text] [Related]
14. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province]. Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342 [No Abstract] [Full Text] [Related]
15. Benefits of early hepatitis B immunization programs for newborns and infants. Van Herck K; Van Damme P Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823 [TBL] [Abstract][Full Text] [Related]
16. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination. Anderson S; Harper LM; Dionne-Odom J; Halle-Ekane G; Tita ATN Int J Gynaecol Obstet; 2018 Apr; 141(1):126-132. PubMed ID: 29315536 [TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of universal newborn hepatitis B vaccination in China. Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. Beutels P; Edmunds WJ; Antoñanzas F; De Wit GA; Evans D; Feilden R; Fendrick AM; Ginsberg GM; Glick HA; Mast E; Péchevis M; Van Doorslaer EK; van Hout BA; Pharmacoeconomics; 2002; 20(1):1-7. PubMed ID: 11817988 [TBL] [Abstract][Full Text] [Related]
19. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits. Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection. Holliday SM; Faulds D Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]